Gene · 1848
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-5p/dual-specificity phosphatase 6 axis. | Ren Fail | 2023 | 36794657 | PubTator, text mining | PubMed |
| Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer. | Theranostics | 2023 | 36793866 | PubTator, text mining | PubMed |
| Identification of novel targets and pathways to distinguish suicide dependent or independent on depression diagnosis. | Sci Rep | 2023 | 36781900 | PubTator, text mining | PubMed |
| The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives. | Int J Mol Sci | 2023 | 36769267 | PubTator, text mining | PubMed |
| DEHP Decreases Steroidogenesis through the cAMP and ERK1/2 Signaling Pathways in FSH-Stimulated Human Granulosa Cells. | Cells | 2023 | 36766740 | PubTator, text mining | PubMed |
| Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome. | Cells | 2023 | 36766731 | PubTator, text mining | PubMed |
| Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research. | Cancers (Basel) | 2023 | 36765545 | PubTator, text mining | PubMed |
| Dual-specificity phosphatases 22-deficient T cells contribute to the pathogenesis of ankylosing spondylitis. | BMC Med | 2023 | 36765305 | PubTator, text mining | PubMed |
| Integrative competing endogenous RNA network analyses identify novel lncRNA and genes implicated in metastatic breast cancer. | Sci Rep | 2023 | 36765262 | PubTator, text mining | PubMed |
| A novel missense variant of FGFR1 in a Japanese girl with Kallmann syndrome and holoprosencephaly. | Clin Pediatr Endocrinol | 2023 | 36761495 | PubTator, text mining | PubMed |
| Multi-omics and machine learning reveal context-specific gene regulatory activities of PML::RARA in acute promyelocytic leukemia. | Nat Commun | 2023 | 36759620 | PubTator, text mining | PubMed |
| Explainable artificial intelligence model for identifying COVID-19 gene biomarkers. | Comput Biol Med | 2023 | 36738712 | PubTator, text mining | PubMed |
| Defective jagged-1 signaling affects GnRH development and contributes to congenital hypogonadotropic hypogonadism. | JCI Insight | 2023 | 36729644 | PubTator, text mining | PubMed |
| Gonadotropin administration to mimic mini-puberty in hypogonadotropic males: pump or injections? | Endocr Connect | 2023 | 36724045 | PubTator, text mining | PubMed |
| High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer. | PLoS One | 2023 | 36706086 | PubTator, text mining | PubMed |
| Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial. | Nat Med | 2023 | 36702949 | PubTator, text mining | PubMed |
| Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer. | NPJ Precis Oncol | 2023 | 36702855 | PubTator, text mining | PubMed |
| Clinical Characteristics and Genetic Analyses of Patients with Idiopathic Hypogonadotropic Hypogonadism | J Clin Res Pediatr Endocrinol | 2023 | 36700485 | PubTator, text mining | PubMed |
| Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance. | Mol Syst Biol | 2023 | 36700386 | PubTator, text mining | PubMed |
| Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis. | JID Innov | 2023 | 36699197 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1848/papers?page=17